Pharmacologic strategies for augmenting cognitive performance in schizophrenia. (Q52180294)

26 April 2018

review article

1 reference

title

Pharmacologic strategies for augmenting cognitive performance in schizophrenia. (English)

1 reference

26 April 2018

0 references

1 reference

Friedman JI

1

1 reference

26 April 2018

Temporini H

series ordinal

2

1 reference

26 April 2018

Davis KL

series ordinal

3

1 reference

26 April 2018

language of work or name

English

0 references

publication date

1 January 1999

1 reference

26 April 2018

published in

Biological Psychiatry

1 reference

26 April 2018

volume

45

1 reference

26 April 2018

issue

1

1 reference

26 April 2018

page(s)

1-16

1 reference

26 April 2018

Cognitive functioning and positive and negative symptoms in schizophrenia

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Changes in the brain catecholamines in patients with dementia of Alzheimer type.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Removal of the hippocampus and transection of the fornix produce comparable deficits on delayed non-matching to position by rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

The effects of physostigmine and scopolamine on recognition memory in monkeys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Impaired Learning and Decreased Cortical Norepinephrine after Bilateral Locus Coeruleus Lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Opiate- and alpha 2-adrenoceptor-induced hyperpolarizations of locus ceruleus neurons in brain slices: reversal by cyclic adenosine 3':5'-monophosphate analogues.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Selective prefrontal cortical projections to the region of the locus coeruleus and raphe nuclei in the rhesus monkey.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Alpha 2-adrenergic mechanisms in prefrontal cortex associated with cognitive decline in aged nonhuman primates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

The alpha-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects: evidence for alpha-2 receptor subtypes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

The contribution of alpha 2-noradrenergic mechanisms of prefrontal cortical cognitive function. Potential significance for attention-deficit hyperactivity disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

7 January 2021

Short-term memory in the rhesus monkey: disruption from the anti-cholinergic scopolamine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Physostigmine and Recent Memory: Effects in Young and Aged Nonhuman Primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Memory deficits following chronic alcohol consumption in mice: relationships with hippocampal and cortical cholinergic activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. IV. Further evidence for regional and behavioral specificity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Intellectual deficits in first-episode schizophrenia: evidence for progressive deterioration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Brain Norepinephrine and Dopamine in Schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Deficits in passive-avoidance learning following atropine in the developing rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Selective loss of neurones of origin of adrenergic projection to cerebral cortex (nucleus locus coeruleus) in senile dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

National Institute of Mental Health longitudinal study of chronic schizophrenia. Prognosis and predictors of outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Memory and the septo-hippocampal cholinergic system in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Cognitive Deficit Caused by Regional Depletion of Dopamine in Prefrontal Cortex of Rhesus Monkey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

6-Hydroxydopamine lesion of the rat prefrontal cortex increases locomotor activity, impairs acquisition of delayed alternation tasks, but does not affect uninterrupted tasks in the radial maze

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

The comparative efficacy and long-term effect of clozapine treatment on neuropsychological test performance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Continuous ICV infusion of scopolamine impairs sustained attention of rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Effects of lesions to ascending noradrenergic neurones on performance of a 5-choice serial reaction task in rats; implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Spatial working memory deficits and their relationship to negative symptoms in unmedicated schizophrenia patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

d-Cycloserine adjuvant therapy to conventional neuroleptic treatment in schizophrenia: an open-label study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Physostigmine and arecoline: effects of intravenous infusions in Alzheimer presenile dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Neuroleptic drug effects on cognitive function in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Dopamine receptors in human brain: autoradiographic distribution of D1 sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Pharmacological manipulations of the alpha 2-noradrenergic system. Effects on cognition.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Cortical Synapses and Reinforcement: a Hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Monoamine Mechanisms in Chronic Schizophrenia: Post-Mortem Neurochemical Findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Differential effects of clozapine and haloperidol on dopamine receptor mRNA expression in rat striatum and cortex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

The effect of apomorphine on regional cerebral blood flow in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Effects of the D-1 agonist SKF-38393 combined with haloperidol in schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Severity of symptoms in chronically institutionalized geriatric schizophrenic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Cognitive functioning in late-life schizophrenia: a comparison of elderly schizophrenic patients and patients with Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Physostigmine: Improvement of Long-Term Memory Processes in Normal Humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Induction of depression with oxotremorine in patients with Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Dopamine in schizophrenia: a review and reconceptualization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Activation of the noradrenergic system facilitates an attentional shift in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Effects of antipsychotics on cognitive behaviour in rats using the delayed non-match to position paradigm.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Memory and cognitive function in man: Does the cholinergic system have a specific role?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Memory decline in the aged: treatment with lecithin and physostigmine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Comparative effects of cholinergic drugs and lesions of nucleus basalis or fimbria-fornix on delayed matching in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Continuous performance tests in schizophrenic patients: stimulus and medication effects on performance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Two functional components of the hippocampal memory system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Neuropsychological evidence for frontostriatal dysfunction in schizophrenia

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

7 January 2021

The nucleus basalis of Meynert, senile plaques, and intellectual impairment in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Homovanillic acid concentrations in brain, CSF and plasma as indicators of central dopamine function in primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Increased hippocampal acetylcholine release during a working memory task.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Norepinephrine in Chronic Paranoid Schizophrenia: Above-Normal Levels in Limbic Forebrain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Clonidine improves memory function in schizophrenia independently from change in psychosis. Preliminary findings.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Visuospatial working memory in patients with schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Verbal working memory dysfunction in schizophrenia: use of a Brown-Peterson paradigm.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Differential regulation of molecular subtypes of muscarinic receptors in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Auditory working memory and Wisconsin Card Sorting Test performance in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Further evidence for dementia of the prefrontal type in schizophrenia? A controlled study of teaching the Wisconsin Card Sorting Test.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Recall memory deficit in schizophrenia. A possible manifestation of prefrontal dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Cognitive and behavioral effects of the coadministration of dextroamphetamine and haloperidol in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

The effect of clozapine on cognition and psychiatric symptoms in patients with schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Regional and cellular fractionation of working memory

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Overlap of dopaminergic, adrenergic, and serotoninergic receptors and complementarity of their subtypes in primate prefrontal cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

D-cycloserine added to clozapine for patients with schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

What are the functional consequences of neurocognitive deficits in schizophrenia?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Does risperidone improve verbal working memory in treatment-resistant schizophrenia?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Place navigation in rats is impaired by lesions of medial septum and diagonal band but not nucleus basalis magnocellularis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Memory access pathway: Role of adrenergic versus cholinergic neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Facilitative effects of the ampakine CX516 on short-term memory in rats: enhancement of delayed-nonmatch-to-sample performance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Facilitative effects of the ampakine CX516 on short-term memory in rats: correlations with hippocampal neuronal activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Cortical cholinergic markers in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Serotonergic regulation of associative learning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Cognitive impairment and negative symptoms in geriatric chronic schizophrenic patients: a follow-up study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

The effects of clozapine on symptom reduction, neurocognitive function, and clinical management in treatment-refractory state hospital schizophrenic inpatients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

RS 86 in the treatment of Alzheimer's disease: cognitive and biological effects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Enhancement by an ampakine of memory encoding in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Neuropsychological correlates of central monoamine function in chronic schizophrenia: relationship between CSF metabolites and cognitive function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Adrenergic receptors in aging and Alzheimer's disease: increased beta 2-receptors in prefrontal cortex and hippocampus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Cloning, sequencing, and expression of the gene coding for the human platelet alpha 2-adrenergic receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Schizophrenia: elevated cerebrospinal fluid norepinephrine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Noradrenergic changes and memory loss in aged mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Prenatal nicotine effects on memory in rats: pharmacological and behavioral challenges.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

A common action of clozapine, haloperidol, and remoxipride on D1- and D2-dopaminergic receptors in the primate cerebral cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Evidence that a positive modulator of AMPA-type glutamate receptors improves delayed recall in aged humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Cognitive enhancement in Korsakoff's psychosis by clonidine: a comparison with L-dopa and ephedrine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Dementia and cerebral noradrenergic innervation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Changes in the Monoamine Containing Neurones of the Human Cns in Senile Dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

The effects of AMPA-induced lesions of the septo-hippocampal cholinergic projection on aversive conditioning to explicit and contextual cues and spatial learning in the water maze.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Memory impairment in Korsakoff's psychosis: a correlation with brain noradrenergic activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Nucleus basalis magnocellularis and medial septal area lesions differentially impair temporal memory.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Characteristics of memory impairment following lesioning of the basal forebrain and medial septal nucleus in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Choline chloride effects on memory in the elderly☆

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Attentional functions of the forebrain cholinergic systems: effects of intraventricular hemicholinium, physostigmine, basal forebrain lesions and intracortical grafts on a multiple-choice serial reaction time task

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Clozapine reverses the spatial working memory deficits induced by FG7142 in monkeys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Correlation of brain levels of 9-amino-1,2,3,4-tetrahydroacridine (THA) with neurochemical and behavioral changes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Spatial learning and memory following fimbria-fornix transection and grafting of fetal septal neurons to the hippocampus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Information processing and attentional functioning in the developmental course of schizophrenic disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Selective attention dysfunctions in adult rats neonatally treated with 6-hydoxydopamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Dissociable effects on spatial maze and passive avoidance acquisition and retention following AMPA- and ibotenic acid-induced excitotoxic lesions of the basal forebrain in rats: differential dependence on cholinergic neuronal loss

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Association of an oculomotor delayed response task and the Wisconsin Card Sort Test in schizophrenic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Schizophrenics show spatial working memory deficits.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Effects of cholinergic drugs on delayed match-to-sample performance of rhesus monkeys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Effects of Alzheimer's disease and normal aging on cerebrospinal fluid norepinephrine responses to yohimbine and clonidine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Clinical and biologic response to clozapine in patients with schizophrenia. Crossover comparison with fluphenazine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Symptom stability in geriatric chronic schizophrenic inpatients: a one-year follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Norepinephrine and MHPG levels in CSF and plasma in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Comparative effects of ibotenic acid- and quisqualic acid-induced lesions of the substantia innominata on attentional function in the rat: further implications for the role of the cholinergic neurons of the nucleus basalis in cognitive processes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Some evidence for the involvement of adrenergic sites in the memory trace

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

D-cycloserine adjuvant therapy to molindone in the treatment of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Differential effects of three 5-HT receptor antagonists on the performance of rats in attentional and working memory tasks.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Enhanced performance of spatial and visual recognition memory tasks by the selective acetylcholinesterase inhibitor E2020 in rhesus monkeys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Inhibitory influence of frontal cortex on locus coeruleus neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

D1 Dopamine Receptors in Prefrontal Cortex: Involvement in Working Memory

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

The role of D1-dopamine receptor in working memory: local injections of dopamine antagonists into the prefrontal cortex of rhesus monkeys performing an oculomotor delayed-response task.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Dopamine enhances the neuronal activity of spatial short-term memory task in the primate prefrontal cortex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Neuropsychological function in schizophrenia. Selective impairment in memory and learning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Neuropsychological performance in chronic schizophrenia in response to neuroleptic dose reduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Dopaminergic A10 neurones are involved in cognitive functions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Human Serial Learning: Enhancement with Arecholine and Choline Impairment with Scopolamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

The D1 agonist dihydrexidine releases acetylcholine and improves cognition in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Possible Etiology of Schizophrenia: Progressive Damage to the Noradrenergic Reward System by 6-Hydroxydopamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Memory enhancement by central administration of norepinephrine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Effects of anticholinergic medication on memory in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Selective increase in dopamine metabolism in the prefrontal cortex by the anxiogenic beta-carboline FG 7142.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Selective activation of mesocortical DA system by stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Effects of acute and chronic electroconvulsive shock on noradrenaline release in the rat hippocampus and frontal cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

CSF norepinephrine in schizophrenia is elevated prior to relapse after haloperidol withdrawal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Clonidine treatment of schizophrenia: can we predict treatment response?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Norepinephrine in acute exacerbations of chronic schizophrenia. Negative symptoms revisited

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Neuroleptic effects on neuropsychological test performance in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Cognitive and behavioral effects of cholinergic, dopaminergic, and serotonergic blockade in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Characterization of a novel muscarinic receptor agonist, YM796: comparison with cholinesterase inhibitors in in vivo pharmacological studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Increase of extracellular dopamine in primate prefrontal cortex during a working memory task

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. III. A new cohort and evidence for a monoaminergic mechanism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Effects of serotonin 5-HT(2A/2C) antagonists on associative learning in the rabbit.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Ventricular cerebrospinal fluid monoamine transmitter and metabolite concentrations reflect human brain neurochemistry in autopsy cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

A critical appraisal of CSF monoamine metabolite studies in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Modulation of memory fields by dopamine D1 receptors in prefrontal cortex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Essential role of neocortical acetylcholine in spatial memory

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Preferential activation of dopamine overflow in prefrontal cortex produced by chronic clozapine treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

Reduced dopamine-beta-hydroxylase activity in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

7 January 2021

Theories of the dorsal bundle extinction effect

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

7 January 2021

Clonidine infusion increases uptake of 99mTc-Exametazime in anterior cingulate cortex in Korsakoff's psychosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

7 January 2021

Animal models of Alzheimer's disease: experimental cholinergic denervation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900287-X

7 January 2021

10.1016/S0006-3223(98)00287-X

Identifiers

DOI

1 reference

26 April 2018

PubMed ID

9894570

1 reference

26 April 2018